News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
693,127 Results
Type
Article (40084)
Company Profile (320)
Press Release (652723)
Section
Business (206558)
Career Advice (2024)
Deals (35674)
Drug Delivery (87)
Drug Development (81629)
Employer Resources (170)
FDA (16131)
Job Trends (14977)
News (348546)
Policy (32721)
Tag
Academia (2559)
Alliances (49920)
Alzheimer's disease (1223)
Approvals (16050)
Artificial intelligence (115)
Bankruptcy (355)
Best Places to Work (11527)
Biotechnology (234)
Breast cancer (102)
Cancer (894)
Cardiovascular disease (76)
Career advice (1691)
Cell therapy (199)
Clinical research (64535)
Collaboration (324)
Compensation (158)
COVID-19 (2547)
Cystic fibrosis (78)
Data (838)
Diabetes (129)
Diagnostics (6124)
Earnings (84597)
Employer resources (148)
Events (111569)
Executive appointments (242)
FDA (16563)
Funding (289)
Gene therapy (150)
GLP-1 (559)
Government (4340)
Healthcare (18740)
Infectious disease (2620)
Inflammatory bowel disease (102)
Interviews (312)
IPO (16376)
Job creations (3738)
Job search strategy (1448)
Layoffs (410)
Legal (7920)
Lung cancer (154)
Manufacturing (155)
Medical device (13159)
Medtech (13164)
Mergers & acquisitions (19303)
Metabolic disorders (355)
Neuroscience (1463)
NextGen Class of 2024 (6563)
Non-profit (4490)
Northern California (1191)
Obesity (213)
Opinion (187)
Patents (97)
People (57139)
Phase I (20090)
Phase II (28464)
Phase III (21104)
Pipeline (204)
Postmarket research (2562)
Preclinical (8557)
Radiopharmaceuticals (235)
Rare diseases (180)
Real estate (6051)
Regulatory (21625)
Research institute (2339)
Resumes & cover letters (354)
Southern California (1074)
Startups (3667)
United States (11595)
Vaccines (537)
Weight loss (161)
Date
Today (21)
Last 7 days (786)
Last 30 days (2743)
Last 365 days (36067)
2024 (30474)
2023 (40429)
2022 (51638)
2021 (56113)
2020 (54484)
2019 (46912)
2018 (35348)
2017 (32527)
2016 (32053)
2015 (38032)
2014 (31814)
2013 (26847)
2012 (29162)
2011 (29834)
2010 (27936)
Location
Africa (743)
Arizona (189)
Asia (37938)
Australia (6318)
California (2704)
Canada (1165)
China (211)
Colorado (115)
Connecticut (118)
Europe (81827)
Florida (385)
Georgia (98)
Illinois (332)
Indiana (176)
Kansas (99)
Maryland (511)
Massachusetts (2203)
Michigan (142)
Minnesota (248)
New Jersey (817)
New York (828)
North Carolina (680)
Northern California (1191)
Ohio (124)
Pennsylvania (743)
South America (1132)
Southern California (1074)
Texas (376)
Utah (78)
Washington State (319)
693,127 Results for "operon biotechnologies inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
UNITY Biotechnology, Inc. Reports First Quarter 2024 Financial Results and Business Updates
UNITY Biotechnology, Inc. reported financial results for the first quarter ended March 31, 2024.
May 14, 2024
·
7 min read
Deals
Nika Pharmaceuticals, Inc. (NKPH) Merges With Nika Biotechnology, Inc.
Nika Pharmaceuticals, Inc. (OTCMKTS: NKPH) announces its merger with Nika BioTechnology, Inc., effective as of March 1, 2024.
March 20, 2024
·
2 min read
Business
UNITY Biotechnology, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates
UNITY Biotechnology, Inc. reported financial results for the fourth quarter and full year ended December 31, 2023.
April 15, 2024
·
8 min read
Deals
Arbor Biotechnologies Announces Acquisition of Serendipity
Arbor Biotechnologies, Inc., a biotechnology company discovering and developing the next generation of genetic medicines, announced the acquisition of Serendipity Biosciences, a private biotechnology company focused on the discovery of unique gene editing technologies.
May 8, 2024
·
3 min read
Business
UNITY Biotechnology, Inc. Reports Second Quarter 2024 Financial Results and Business Updates
August 6, 2024
·
7 min read
Press Releases
Lixte Biotechnology Holdings, Inc. to Present at August 20th Virtual Investor Summit Microcap Event
August 15, 2024
·
1 min read
Elixirgen Scientific, Inc. Achieves ISO 9001:2015 Certification, Strengthening Commitment to Quality, Excellence in Biotechnology
Elixirgen Scientific, Inc., a biotechnology leader focused on advancing drug discovery and revolutionizing cell therapy through iPSC technology, announced today that it has been accredited for ISO 9001:2015 certification.
March 8, 2024
·
3 min read
Biotech Bay
Adverum Biotechnologies to Participate in TD Cowen’s Genetic Medicines & RNA Summit
Adverum Biotechnologies, Inc. today announced that Laurent Fischer, M.D., president and chief executive officer of Adverum Biotechnologies, will participate in a fireside chat at TD Cowen’s Genetic Medicines & RNA Summit on Friday, June 21, 2024 at 10:00 a.m. ET.
June 18, 2024
·
1 min read
Press Releases
Sana Biotechnology Highlights Publication in Nature Biotechnology of Novel In Vivo Preclinical Data Showing the Potential for Pluripotent Stem Cell-Derived Human Glial Progenitor Cell Transplantation
Sana Biotechnology, Inc. today highlighted that Nature Biotechnology has published a paper titled “Young glial progenitor cells competitively replace aged and diseased human glia in the adult chimeric mouse brain.”
May 21, 2024
·
6 min read
Biotech Bay
Vir Biotechnology to Host 2024 Annual Meeting of Stockholders
Vir Biotechnology, Inc. (Nasdaq: VIR) today reminds stockholders that it will hold its 2024 Annual Meeting of Stockholders on Wednesday, May 29, 2024, at 9:00 a.m. PT.
May 23, 2024
·
1 min read
1 of 69,313
Next
